Greater portion of patients undergoing hip arthroplasty had hip symptoms vs controls
Click Here to Manage Email Alerts
A recently published retrospective study showed a greater percentage of young, active patients undergoing hip arthroplasty had hip symptoms than patients with no prior hip interventions or those who had hip pathology that limited activity.
An independent, third-party survey center administered a questionnaire to assess patient satisfaction and function among 806 patients younger than 60 years of age who were undergoing hip arthroplasty and had a pre-symptomatic University of California at Los Angeles score of 6 or greater and 158 patients with no prior hip interventions or hip pathology that limited their activity.
Results showed patients in the control group reported the presence of a limp, stiffness in the hip in the last 30 days, pain in the hip in the last 30 days and noise generation from the hip, despite denying any major hip problems. However, researchers found a significantly greater proportion of patients undergoing total hip arthroplasty (THA) or surface replacement arthroplasty reported the presence of a limp, stiffness of in the hip and pain in the hip. According to results, patients in the control group were more likely to report the ability to run or jog in the last 30 days vs. patients in the hip arthroplasty group, and were more likely to participate in their most preferred activity in the last 30 days vs. patients in the THA group.
After surgery, researchers noted patients who underwent hip arthroplasty were more likely to report being more active vs. the control group when compared with 3 years earlier, with 67% of patients in the THA group, 72% of patients in the surface replacement arthroplasty group and 28% of control patients reporting an increase in activity. – by Casey Tingle
Disclosures: Nam reports he is a paid consultant for KCI, has stock or stock options with OrthAlign Inc. and received research support from EOS. Please see the full study for a list of all other authors’ relevant financial disclosures.